<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gregory YH Lip, MD, FRCPE, FESC, FACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jordan M Prutkin, MD, MHA, MHS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bradley P Knight, MD, FACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Atrial fibrillation (AF) can lead to a fall in cardiac output that is often clinically significant. Potential consequences include a fall in blood pressure, decreased exercise capacity, and pulmonary congestion, all of which are manifestations of heart failure (HF). In addition, AF and HF often occur together, and each may predispose to the other [<a href="#rid1">1</a>].</p><p>The hemodynamic effects of AF and of cardioversion will be reviewed here. The clinical aspects and treatment of AF in patients with HF and cardiomyopathy are discussed separately. (See  <a class="medical medical_review" href="/d/html/977.html" rel="external">"The management of atrial fibrillation in patients with heart failure"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ADVERSE HEMODYNAMICS IN AF</span><span class="headingEndMark"> — </span>Many patients with atrial fibrillation (AF) develop a modest decline in left ventricular performance that typically returns to the previous baseline following reversion to sinus rhythm [<a href="#rid2">2-5</a>]. The magnitude of this effect and its reversibility were illustrated in a report of 15 patients with AF who were successfully cardioverted and maintained sinus rhythm for one month; 11 of these patients maintained sinus rhythm for three months [<a href="#rid4">4</a>]. The mean duration of AF was three months (range 5 to 254 days). The following findings were noted after cardioversion:</p><p class="bulletIndent1"><span class="glyph">●</span>The mean left ventricular ejection fraction (LVEF) increased from 47 percent at baseline to 55 percent immediately after cardioversion to 61 percent at one month; there was no further increase at three months. The improvement in LVEF occurred in all but one patient. The maximum improvement in LVEF by one month coincides with the time to full recovery of left atrial contractile function [<a href="#rid6">6</a>]. (See <a class="local">'Atrial stunning'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The increase in LVEF was primarily due to enhanced diastolic filling resulting from two factors: (1) an increase in cycle length, which may involve both regularization of the heart rate and avoidance of short cycle lengths that impair ventricular contractility; and (2) the return of left atrial contractile function, as determined by peak A wave velocity, which increases the atrial contribution to ventricular filling [<a href="#rid3">3,4</a>].</p><p></p><p>The improvement in LVEF following reversion to sinus rhythm is associated with an increase in exercise capacity. (See <a class="local">'Improved exercise capacity'</a> below.)</p><p>The deleterious hemodynamic effects of chronic uncontrolled AF are more pronounced in some patients who develop a reversible tachycardia-mediated cardiomyopathy. (See <a class="local">'Tachycardia-mediated cardiomyopathy'</a> below.)</p><p>Hemodynamic deterioration also occurs in patients with underlying heart failure (HF). This issue was examined in a prospective observational study of 344 patients with HF who were initially in sinus rhythm; 28 developed AF over 19 months, 18 of whom developed chronic AF [<a href="#rid7">7</a>]. Chronic AF was associated with significant worsening of New York Heart Associated functional class (mean 2.4 to 2.9)  (<a class="graphic graphic_table graphicRef52683" href="/d/graphic/52683.html" rel="external">table 1</a>) and a significant reduction in cardiac index (mean 2.2 to 1.8). The relatively modest changes may have reflected excellent control of the ventricular rate (78 beats/min) at the time the measurements were made. Consistent with this hypothesis is the observation that the onset of AF in 8 of the 18 patients with chronic AF was associated with overt cardiac decompensation, which presumably led to therapy to control the ventricular rate. (See  <a class="medical medical_review" href="/d/html/977.html" rel="external">"The management of atrial fibrillation in patients with heart failure"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Contributing factors</span><span class="headingEndMark"> — </span>The following factors may contribute to the adverse hemodynamic changes in AF:</p><p class="bulletIndent1"><span class="glyph">●</span>A rapid or slow heart rate; if maintained, a chronic tachycardia can lead to a rate-related cardiomyopathy (atrial or ventricular).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The irregular rhythm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Loss of atrial systole (also called the atrial "kick") required for optimal ventricular filling.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Activation of neurohumoral vasoconstrictors such as angiotensin II and <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a>.</p><p></p><p>Another problem demonstrated in animal models is that AF may beget AF by causing electrical remodeling of the atria, which promotes perpetuation of the arrhythmia [<a href="#rid8">8,9</a>]. This proarrhythmic process is reversible with the maintenance of sinus rhythm. The clinical relevance of this observation remains uncertain. (See  <a class="medical medical_review" href="/d/html/16402.html" rel="external">"Mechanisms of atrial fibrillation", section on 'Maintenance of atrial fibrillation'</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Rapid ventricular response</span><span class="headingEndMark"> — </span>The dependence of cardiac output on heart rate is greatest in patients with left ventricular dysfunction, which is often associated with a relatively fixed stroke volume. As an example, the cardiac output is optimal over a narrow range of heart rates in patients with a myocardial infarction, falling significantly with slower or faster heart rates [<a href="#rid10">10</a>]. A rapid ventricular response is also particularly deleterious in patients with mitral stenosis in whom the reduction in the duration of diastole diminishes the time available for filling of the left ventricle across the stenotic valve [<a href="#rid11">11</a>].</p><p>The optimal heart rate for patients in permanent AF is discussed separately. (See  <a class="medical medical_review" href="/d/html/938.html" rel="external">"Control of ventricular rate in patients with atrial fibrillation who do not have heart failure: Pharmacologic therapy", section on 'Evaluation and goal ventricular rate'</a>.)</p><p class="headingAnchor" id="H5"><span class="h4">Tachycardia-mediated cardiomyopathy</span><span class="headingEndMark"> — </span>Persistent, uncontrolled tachycardia can have a cardiomyopathic effect that impairs left ventricular function. This phenomenon is called a tachycardia-mediated cardiomyopathy and is reversible when the tachycardia is controlled. (See  <a class="medical medical_review" href="/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy"</a>.)</p><p>AF occurs in 10 to 30 percent of patients with HF but can be even higher as heart failure worsens. In most of these patients, the underlying heart disease is thought to predispose to AF. (See  <a class="medical medical_review" href="/d/html/977.html" rel="external">"The management of atrial fibrillation in patients with heart failure"</a>.) However, in some patients, restoration of sinus rhythm or control of the rapid ventricular response markedly improves or even normalizes the LVEF, indicating that the left ventricular dysfunction was primarily due to the rapid AF rather than an underlying dilated cardiomyopathy [<a href="#rid12">12-14</a>]. The benefit may be more predictable with reversion to sinus rhythm [<a href="#rid13">13,15</a>].</p><p>The following observations illustrate the potential magnitude of this effect:</p><p class="bulletIndent1"><span class="glyph">●</span>In one report, the LVEF was measured before and at a mean of 4.7 months after cardioversion in 12 patients with chronic AF and presumed idiopathic dilated cardiomyopathy [<a href="#rid13">13</a>]. There was an improvement in mean LVEF from 32 percent at baseline to 53 percent at follow-up; the LVEF returned to normal in six of the patients. This improvement persisted at one year in the 10 patients who remained in sinus rhythm, while there was a marked deterioration in left ventricular function in the two patients with recurrent AF.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among patients treated with rate control, the largest reported experience comes from the multicenter Ablate and Pace Trial (APT), a prospective registry of patients undergoing atrioventricular (AV) nodal ablation and pacemaker implantation for refractory AF [<a href="#rid14">14</a>]. The registry included 63 patients with left ventricular dysfunction (LVEF ≤45 percent); after atrioventricular (AV) nodal ablation, 16 (25 percent) displayed a marked improvement in LVEF to over 45 percent. The mean increase in LVEF in these patients was 27 percentage points.</p><p></p><p class="headingAnchor" id="H6"><span class="h3">Irregular heart rate</span><span class="headingEndMark"> — </span>The hypothesis that an irregular rhythm itself, independent of the ventricular rate and the restoration of atrial systole, can impair hemodynamics is based in part upon short-term observations that irregular ventricular pacing or induced AF results in a decrease in cardiac output, an elevation in central venous pressure, and an increase in sympathetic nerve activity compared to regular ventricular or atrial pacing at the same mean heart rate [<a href="#rid16">16,17</a>].</p><p>Further support for the adverse effect of an irregular heart rate comes from a study of 14 patients with chronic AF and a normal ventricular response in the absence of drugs that block AV nodal conduction [<a href="#rid18">18</a>]. AV nodal ablation and insertion of a ventricular pacemaker resulted in a regular rhythm, improvements in left ventricular function, functional capacity, and the sense of well-being [<a href="#rid18">18</a>].</p><p>The adverse hemodynamic effect of an irregular rhythm may be mediated by several factors:</p><p class="bulletIndent1"><span class="glyph">●</span>Beat-to-beat variations in atrial pressure (preload). The influence of preload on left ventricular ejection (Frank-Starling mechanism) is important in AF only when afterload is relatively low [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beat-to-beat variations in myocardial contractility [<a href="#rid20">20-22</a>]. Among patients with AF, the preceding RR interval has a significant positive correlation with left ventricular ejection, as a shorter RR interval (more rapid ventricular response) reduces the LVEF [<a href="#rid20">20</a>]. This effect is independent of end-diastolic volume, indicating that it cannot be explained by the Frank-Starling mechanism. In addition, the "pre-preceding" RR interval has a <strong>negative</strong> correlation with left ventricular ejection, which has been ascribed to postextrasystolic potentiation [<a href="#rid20">20,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inefficient ventricular mechanics due to abrupt changes in cycle length [<a href="#rid16">16</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Atrial systole</span><span class="headingEndMark"> — </span>Contraction of the left atrium injects a volume of blood under pressure into the left ventricle, leading to increments in ventricular diastolic volume, end-diastolic pressure, and stroke volume [<a href="#rid24">24,25</a>]. Loss of atrial systole can therefore diminish the stroke volume. This may be particularly important when left ventricular compliance is reduced and in mitral stenosis.</p><p>Left ventricular compliance is reduced in patients with diastolic dysfunction. In such patients, there is a relative shift of left ventricular filling to the later part of diastole with a greater dependence upon atrial contraction. Clinical examples in which AF can lead to hemodynamic deterioration in patients with diastolic dysfunction include advanced aortic stenosis, which often produces a hypertrophied, poorly compliant left ventricle, and hypertrophic cardiomyopathy. </p><p>The importance of atrial systole has been demonstrated in patients with hypertrophic cardiomyopathy, which is typically associated with an increased atrial contribution to ventricular filling (31 versus 16 percent in controls in one report) [<a href="#rid26">26</a>]. In addition, loss of the atrial contraction-induced increase in left ventricular end-diastolic volume can increase the degree of outflow tract obstruction. The net effect is that the acute onset of AF leads to worsening symptoms in the great majority of patients with hypertrophic cardiomyopathy (41 of 46 in one study) [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/d/html/4926.html" rel="external">"Hypertrophic cardiomyopathy in adults: Supraventricular tachycardias including atrial fibrillation"</a> and  <a class="medical medical_review" href="/d/html/3457.html" rel="external">"Pathophysiology of heart failure with preserved ejection fraction"</a>.)</p><p>Among patients with mitral stenosis, the onset of AF can lead to hemodynamic deterioration. Two factors contribute to this adverse effect: the loss in atrial systole, which plays an important role in the generation of adequate left atrial pressure to maintain blood flow across the stenotic valve and may also reduce effective mitral valve area; and the rapid ventricular response which, due to the reduction in the duration of diastole, diminishes the time available for filling of the left ventricle [<a href="#rid11">11</a>]. </p><p>The relevance of atrial systole, irregular rate, and ejection fraction was assessed in patients with systolic HF who underwent AF ablation versus AV node ablation with biventricular pacing [<a href="#rid28">28</a>]. In those who underwent AF ablation, there was a greater improvement in ejection fraction, six-minute walk test, and quality-of-life scores. It is not clear, however, whether it was due to the restoration of sinus rhythm in the AF group or presence of pacing, even though it was biventricular, in the AV node ablation group. </p><p class="headingAnchor" id="H8"><span class="h3">Neurohumoral activation</span><span class="headingEndMark"> — </span>The fall in cardiac output in rapid AF may increase afterload by activating neurohumoral vasoconstrictors. In addition, AF may reversibly increase the secretion of atrial natriuretic peptide [<a href="#rid29">29,30</a>] which, via activation of other propeptides and neurohumoral mechanisms, could influence systemic hemodynamics. As an example, one study of 100 patients with and without AF found that patients with AF had higher levels of N-terminal atrial natriuretic peptide (ANP) (2.6 versus 1.7 ng/mL in those without AF); this association was independent of left atrial volume and LVEF [<a href="#rid31">31</a>]. In patients with HF and AF, the association between AF and ANP interferes with the association between left ventricular dysfunction and ANP. </p><p>While one study did not find a higher level of plasma B-type natriuretic peptide (BNP) in AF patients compared to those without [<a href="#rid31">31</a>], other studies have [<a href="#rid32">32,33</a>]. (See  <a class="medical medical_review" href="/d/html/3486.html" rel="external">"Natriuretic peptide measurement in heart failure"</a>.) The relationship between baseline BNP and recurrence of AF after successful AF ablation is discussed elsewhere. </p><p class="headingAnchor" id="H6881060"><span class="h3">Mitral regurgitation</span><span class="headingEndMark"> — </span>Preliminary data has suggested that, in a small number of patients, AF can lead to increased mitral annular dilatation and mitral regurgitation (MR). This was shown in a report of 12 patients (out of 18,695 open heart surgeries) who had AF and moderate or greater MR, with normal left ventricular size and function but symptoms of dyspnea [<a href="#rid34">34</a>]. They underwent mitral ring annuloplasty and surgical ablation, with an improvement in symptoms and MR. The presence of AF can create a cycle of worsening AF burden and increasing MR, which can be reversed with a persistent return to normal sinus rhythm [<a href="#rid35">35</a>]. Increased left atrial size in the presence of normal left ventricular function has been associated with increased mitral annular size and more severe MR in some studies [<a href="#rid36">36</a>], but not in all [<a href="#rid37">37,38</a>].</p><p class="headingAnchor" id="H9"><span class="h1">HEMODYNAMICS AFTER CONVERSION OF CHRONIC AF TO SINUS RHYTHM</span><span class="headingEndMark"> — </span>As noted above, the restoration of sinus rhythm produces a rapid increase in left ventricular ejection fraction (LVEF) in most patients with atrial fibrillation (AF) [<a href="#rid2">2-4</a>]. In one report, for example, the LVEF increased from 47 to 55 percent immediately after cardioversion and to 61 percent at one month [<a href="#rid4">4</a>]. The improvement in LVEF was primarily due to enhanced diastolic filling resulting from two factors: an increase in cycle length, which may involve both regularization of the heart rate and avoidance of short cycle lengths that impair ventricular contractility; and the return of left atrial contractile function. There appears to be no change in markers of intrinsic myocardial contractility.</p><p>A similar improvement in LVEF has been demonstrated in patients treated with radiofrequency catheter ablation to maintain sinus rhythm. The magnitude of this effect was illustrated in a report of 58 patients with heart failure and AF in whom the mean LVEF improved from 35 to 56 percent and the mean New York Heart Association (NYHA) class fell from 2.3 to 1.4  (<a class="graphic graphic_table graphicRef52683" href="/d/graphic/52683.html" rel="external">table 1</a>) after successful ablation [<a href="#rid39">39</a>]. The greatest improvement was seen within the first three months. (See  <a class="medical medical_review" href="/d/html/977.html" rel="external">"The management of atrial fibrillation in patients with heart failure", section on 'Rhythm control'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Atrial stunning</span><span class="headingEndMark"> — </span>Cardioversion of AF leads to an increased risk of thromboembolism, particularly if patients are not anticoagulated before, during, and after the procedure. Most emboli occur within the first week after cardioversion. In addition to dislodgement of pre-existing thrombi, some patients develop de novo thrombi that are thought to be due at least in part to persistent depression of left atrial systolic function, which can last for several weeks after successful cardioversion [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/906.html" rel="external">"Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation", section on 'Rationale for anticoagulation'</a>.)</p><p>The transient atrial contractile dysfunction following cardioversion, also known as atrial "stunning," may result from a tachycardia-induced atrial cardiomyopathy, which is caused in part by impaired cellular handling of calcium [<a href="#rid40">40-42</a>]. An evaluation of stunning in a canine model revealed the following [<a href="#rid43">43</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Stunning occurred with AF duration of only one hour. In this study and in reports of humans with AF and atrial flutter [<a href="#rid42">42,44</a>], the peak left atrial contractile velocities were lower after reversion to sinus rhythm than during the arrhythmia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stunning was more profound and of longer duration in the left atrial appendage than the left atrium itself.</p><p></p><p>Reduced left atrial appendage function occurs with all forms of reversion to sinus rhythm including spontaneous cardioversion [<a href="#rid45">45</a>], external or internal direct current (DC) (electric) cardioversion [<a href="#rid6">6,44,46-49</a>], and pharmacologic cardioversion [<a href="#rid50">50</a>]. The degree of stunning appears to be greater after electrical compared to spontaneous or pharmacologic cardioversion [<a href="#rid45">45</a>], but is not related to the total amount of energy used if electrical cardioversion is performed [<a href="#rid46">46,47</a>].</p><p>Estimates of the frequency of early atrial stunning (immediately to within three days post-cardioversion) range from 20 to 55 percent [<a href="#rid44">44-46</a>]. At one week, the rate is 10 to 25 percent [<a href="#rid45">45,46</a>].</p><p>The net effect of stunning is that left atrial contractility is reduced by up to 75 percent [<a href="#rid41">41</a>] and left appendage flow velocity falls after the restoration of sinus rhythm [<a href="#rid42">42,44</a>], which can lead to local stasis, as manifested by the onset of or an increase in spontaneous echo contrast [<a href="#rid44">44,48,49</a>], and the formation of new thrombi [<a href="#rid48">48,51-53</a>]. (See  <a class="medical medical_review" href="/d/html/906.html" rel="external">"Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation", section on 'Rationale for anticoagulation'</a>.)</p><p>The duration of the left atrial dysfunction is related in part to the duration of AF [<a href="#rid6">6,50</a>]. In a review of 60 patients who underwent successful cardioversion, full recovery of atrial mechanical function was attained within 24 hours in patients with AF for ≤2 weeks, within one week in patients with AF for two to six weeks, and within one month with more prolonged AF [<a href="#rid6">6</a>]. Recovery of atrial function is typically demonstrated by return of peak A wave velocity on Doppler echocardiography [<a href="#rid6">6,50</a>].</p><p>The time course of recovery of left atrial function could explain why the great majority of embolic events in patients who remain in sinus rhythm occur within the first 10 days after cardioversion [<a href="#rid54">54,55</a>].</p><p>De novo thrombus formation can also result in part from activation of the coagulation system and a hypercoagulable state following cardioversion [<a href="#rid56">56-58</a>]. In one study, for example, an increase in plasma concentrations of the markers of thrombin generation and activity (thrombin-antithrombin complex and fibrinopeptide A) was found soon after pharmacologic cardioversion to sinus rhythm [<a href="#rid56">56</a>]. As with atrial function, hemostatic markers return to normal by two to four weeks after cardioversion [<a href="#rid57">57,58</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Pulmonary edema</span><span class="headingEndMark"> — </span>An uncommon hemodynamic complication of DC cardioversion is pulmonary edema. In a review of the literature, pulmonary edema was reported in approximately 1.2 percent of cases, half of them within three hours but as late as four days after cardioversion [<a href="#rid59">59</a>]. A lower incidence of 0.4 percent was noted in a report of consecutive outpatient cardioversions at a single institution [<a href="#rid60">60</a>]. Pulmonary edema after cardioversion is more common in patients with left ventricular dysfunction or valvular heart disease [<a href="#rid59">59</a>].</p><p>Possible mechanisms for the development of pulmonary edema after cardioversion include acute left ventricular contractile dysfunction [<a href="#rid61">61</a>], which may be due in part to transient interruption of myocardial cellular respiration [<a href="#rid62">62</a>], acute left atrial dysfunction [<a href="#rid46">46</a>], and the return of right atrial before left atrial systolic function [<a href="#rid63">63</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Improved exercise capacity</span><span class="headingEndMark"> — </span>As mentioned above, most patients in whom AF is reverted to sinus rhythm have a significant increase in LVEF [<a href="#rid2">2-4</a>]. One beneficial effect of the improvement in hemodynamics is enhanced exercise capacity [<a href="#rid64">64-66</a>].</p><p>The magnitude of this effect was illustrated in a study of 63 consecutive patients with chronic AF who were electrically cardioverted in whom peak oxygen consumption (peak VO2) was measured before and one month after cardioversion [<a href="#rid65">65</a>]. At one month, the mean peak VO2 in the 37 patients in sinus rhythm had significantly increased from 21.4 to 23.7 mL/min per kg, while those who had reverted to AF showed no change in oxygen consumption. The patients who remained in sinus rhythm also had a significant reduction in peak heart rate and an improvement in NYHA functional class. The benefits from restoration of sinus rhythm were seen in patients with and without underlying heart disease and showed some further improvement at two-year follow-up.</p><p>Similar benefits were noted in the radiofrequency ablation study of 58 patients with heart failure (HF) cited above [<a href="#rid39">39</a>]. The mean NYHA class significantly improved from 2.3 to 1.4 after ablation in association with improvements in quality of life, exercise capacity, and exercise time. (See  <a class="medical medical_review" href="/d/html/977.html" rel="external">"The management of atrial fibrillation in patients with heart failure", section on 'Rhythm control'</a>.)</p><p class="headingAnchor" id="H6881162"><span class="h3">Mitral regurgitation</span><span class="headingEndMark"> — </span>A study of 53 patients examined the effect of AF ablation in those with at least moderate mitral regurgitation (MR) and ejection fraction ≥50 percent compared to those with only mild or less MR [<a href="#rid35">35</a>]. At baseline, those with at least moderate MR were more likely to have persistent AF, older age, and larger mitral annular dimension. Of those who had a successful AF ablation with no recurrence during follow-up, 76 percent had a reduction in MR to mild or less, whereas only 18 percent in the group with an AF recurrence had an improvement in MR. In addition, those with an apparently successful ablation were found to have a decrease in left atrial volume, mitral annular dimension, and mitral annular jet area, with no change in ejection fraction or left ventricular end diastolic dimension, though there was a small decrease in left ventricular end systolic dimension. The authors use the term “atrial functional mitral regurgitation” to describe an enlarged left atrium leading to MR in the absence of pathology of the mitral valve, which can improve by AF ablation that decreases left atrial size. The exact relationship to symptoms or mortality associated with this is unknown at the current time.</p><p class="headingAnchor" id="H267711034"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Many patients with atrial fibrillation (AF) develop a modest decline in left ventricular performance that typically returns to the previous baseline following reversion to sinus rhythm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The following factors may contribute to the adverse hemodynamic changes in AF:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A rapid or slow heart rate; if maintained, a chronic tachycardia can lead to a rate-related cardiomyopathy (atrial or ventricular).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The irregular rhythm.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Loss of atrial systole required for optimal ventricular filling.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Activation of neurohumoral vasoconstrictors. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased mitral regurgitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The restoration of sinus rhythm produces a rapid increase in left ventricular systolic performance in most patients with AF. This translates into an improvement in exercise capacity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A transient atrial contractile dysfunction may follow cardioversion; it is also known as atrial "stunning.” Atrial stunning may result from a tachycardia-induced atrial cardiomyopathy, which is caused in part by impaired cellular handling of calcium.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107:2920.</a></li><li><a class="nounderline abstract_t">Rodman T, Pastor BH, Figueroa W. Effect on cardiac output of conversion from atrial fibrillation to normal sinus mechanism. Am J Med 1966; 41:249.</a></li><li><a class="nounderline abstract_t">Raymond RJ, Lee AJ, Messineo FC, et al. Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J 1998; 136:435.</a></li><li><a class="nounderline abstract_t">Viswanathan K, Daniak SM, Salomone K, et al. Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance. Am J Cardiol 2001; 88:439.</a></li><li><a class="nounderline abstract_t">Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993; 72:560.</a></li><li><a class="nounderline abstract_t">Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535.</a></li><li><a class="nounderline abstract_t">Pozzoli M, Cioffi G, Traversi E, et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998; 32:197.</a></li><li><a class="nounderline abstract_t">Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954.</a></li><li><a class="nounderline abstract_t">Wijffels MC, Kirchhof CJ, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997; 96:3710.</a></li><li><a class="nounderline abstract_t">Shillingford J, Thomas M. Hemodynamic effects of acute myocardial infarction in man. Prog Cardiovasc Dis 1967; 9:571.</a></li><li><a class="nounderline abstract_t">Nicod P, Hillis LD, Winniford MD, Firth BG. Importance of the "atrial kick" in determining the effective mitral valve orifice area in mitral stenosis. Am J Cardiol 1986; 57:403.</a></li><li><a class="nounderline abstract_t">Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1570.</a></li><li><a class="nounderline abstract_t">Kieny JR, Sacrez A, Facello A, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13:1290.</a></li><li><a class="nounderline abstract_t">Redfield MM, Kay GN, Jenkins LS, et al. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000; 75:790.</a></li><li><a class="nounderline abstract_t">Stulak JM, Dearani JA, Daly RC, et al. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg 2006; 82:494.</a></li><li><a class="nounderline abstract_t">Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78:1433.</a></li><li><a class="nounderline abstract_t">Wasmund SL, Li JM, Page RL, et al. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation 2003; 107:2011.</a></li><li><a class="nounderline abstract_t">Natale A, Zimerman L, Tomassoni G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996; 78:1431.</a></li><li><a class="nounderline abstract_t">Muntinga HJ, Gosselink AT, Blanksma PK, et al. Left ventricular beat to beat performance in atrial fibrillation: dependence on contractility, preload, and afterload. Heart 1999; 82:575.</a></li><li><a class="nounderline abstract_t">Gosselink AT, Blanksma PK, Crijns HJ, et al. Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals. J Am Coll Cardiol 1995; 26:1516.</a></li><li><a class="nounderline abstract_t">Brookes CI, White PA, Staples M, et al. Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. Circulation 1998; 98:1762.</a></li><li><a class="nounderline abstract_t">Schneider F, Martin DT, Schick EC, Gaasch WH. Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease. Am J Cardiol 1997; 80:586.</a></li><li><a class="nounderline abstract_t">Hardman SM, Noble MI, Seed WA. Postextrasystolic potentiation and its contribution to the beat-to-beat variation of the pulse during atrial fibrillation. Circulation 1992; 86:1223.</a></li><li><a class="nounderline abstract_t">Rahimtoola SH, Ehsani A, Sinno MZ, et al. Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med 1975; 59:686.</a></li><li><a class="nounderline abstract_t">Linderer T, Chatterjee K, Parmley WW, et al. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation 1983; 67:1045.</a></li><li><a class="nounderline abstract_t">Bonow RO, Frederick TM, Bacharach SL, et al. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 1983; 51:1386.</a></li><li><a class="nounderline abstract_t">Robinson K, Frenneaux MP, Stockins B, et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 15:1279.</a></li><li><a class="nounderline abstract_t">Khan MN, Jaïs P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359:1778.</a></li><li><a class="nounderline abstract_t">Roy D, Paillard F, Cassidy D, et al. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 1987; 9:509.</a></li><li><a class="nounderline abstract_t">Hornestam B, Hall C, Held P, et al. N-terminal proANF in acute atrial fibrillation: a biochemical marker of atrial pressures but not a predictor for conversion to sinus rhythm. Digitalis in Acute Atrial Fibrillation (DAAF) Trial group. Am Heart J 1998; 135:1040.</a></li><li><a class="nounderline abstract_t">Rossi A, Enriquez-Sarano M, Burnett JC Jr, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000; 35:1256.</a></li><li><a class="nounderline abstract_t">Jourdain P, Bellorini M, Funck F, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 2002; 4:263.</a></li><li><a class="nounderline abstract_t">Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92:1124.</a></li><li><a class="nounderline abstract_t">Kihara T, Gillinov AM, Takasaki K, et al. Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation: an echocardiographic study. Echocardiography 2009; 26:885.</a></li><li><a class="nounderline abstract_t">Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol 2011; 58:1474.</a></li><li><a class="nounderline abstract_t">Tanimoto M, Pai RG. Effect of isolated left atrial enlargement on mitral annular size and valve competence. Am J Cardiol 1996; 77:769.</a></li><li><a class="nounderline abstract_t">Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 2002; 39:1651.</a></li><li><a class="nounderline abstract_t">Zhou X, Otsuji Y, Yoshifuku S, et al. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J 2002; 66:913.</a></li><li><a class="nounderline abstract_t">Hsu LF, Jaïs P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351:2373.</a></li><li><a class="nounderline abstract_t">Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 1998; 98:719.</a></li><li><a class="nounderline abstract_t">Schotten U, Ausma J, Stellbrink C, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001; 103:691.</a></li><li><a class="nounderline abstract_t">Sanders P, Morton JB, Morgan JG, et al. Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation 2002; 106:1806.</a></li><li><a class="nounderline abstract_t">Louie EK, Liu D, Reynertson SI, et al. "Stunning" of the left atrium after spontaneous conversion of atrial fibrillation to sinus rhythm: demonstration by transesophageal Doppler techniques in a canine model. J Am Coll Cardiol 1998; 32:2081.</a></li><li><a class="nounderline abstract_t">Grimm RA, Stewart WJ, Maloney JD, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993; 22:1359.</a></li><li><a class="nounderline abstract_t">Mattioli AV, Castelli A, Andria A, Mattioli G. Clinical and echocardiographic features influencing recovery of atrial function after cardioversion of atrial fibrillation. Am J Cardiol 1998; 82:1368.</a></li><li><a class="nounderline abstract_t">Harjai K, Mobarek S, Abi-Samra F, et al. Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. Am J Cardiol 1998; 81:1125.</a></li><li><a class="nounderline abstract_t">Omran H, Jung W, Rabahieh R, et al. Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 1997; 29:131.</a></li><li><a class="nounderline abstract_t">Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23:307.</a></li><li><a class="nounderline abstract_t">Falcone RA, Morady F, Armstrong WF. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. Am J Cardiol 1996; 78:435.</a></li><li><a class="nounderline abstract_t">Shapiro EP, Effron MB, Lima S, et al. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 1988; 62:1202.</a></li><li><a class="nounderline abstract_t">Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995; 129:1204.</a></li><li><a class="nounderline abstract_t">Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89:2509.</a></li><li><a class="nounderline abstract_t">Moreyra E, Finkelhor RS, Cebul RD. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. Am Heart J 1995; 129:71.</a></li><li><a class="nounderline abstract_t">Gentile F, Elhendy A, Khandheria BK, et al. Safety of electrical cardioversion in patients with atrial fibrillation. Mayo Clin Proc 2002; 77:897.</a></li><li><a class="nounderline abstract_t">Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol 1998; 82:1545.</a></li><li><a class="nounderline abstract_t">Oltrona L, Broccolino M, Merlini PA, et al. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. Circulation 1997; 95:2003.</a></li><li><a class="nounderline abstract_t">Lip GY, Rumley A, Dunn FG, Lowe GD. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Int J Cardiol 1995; 51:245.</a></li><li><a class="nounderline abstract_t">Abe, Y, Kim, et al. Evidence for the intravascular hyperclotting state induced by atrial fibrillation itself (abstract). J Am Coll Cardiol 1996; 27(Suppl A):35A.</a></li><li><a class="nounderline abstract_t">Upshaw CB Jr. Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch Intern Med 1997; 157:1070.</a></li><li><a class="nounderline abstract_t">Botkin SB, Dhanekula LS, Olshansky B. Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 2003; 145:233.</a></li><li><a class="nounderline abstract_t">Fung KC, Tan HC, Kritharides L. Acute reductions in ventricular myocardial tissue velocities after direct current cardioversion of atrial fibrillation. J Am Soc Echocardiogr 2003; 16:656.</a></li><li><a class="nounderline abstract_t">Trouton TG, Allen JD, Young IS, et al. Altered cardiac oxygen extraction, lactate production and coronary blood flow after large dose transthoracic DC countershocks. Pacing Clin Electrophysiol 1993; 16:1304.</a></li><li><a class="nounderline abstract_t">Mayosi BM, Commerford PJ. Pulmonary edema following electrical cardioversion of atrial fibrillation. Chest 1996; 109:278.</a></li><li><a class="nounderline abstract_t">Atwood JE, Myers J, Sullivan M, et al. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am Heart J 1989; 118:913.</a></li><li><a class="nounderline abstract_t">Gosselink AT, Crijns HJ, van den Berg MP, et al. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J 1994; 72:161.</a></li><li><a class="nounderline abstract_t">Gosselink AT, Bijlsma EB, Landsman ML, et al. Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up. Eur Heart J 1994; 15:1368.</a></li></ol></div><div id="topicVersionRevision">Topic 1041 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771006" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5912302" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Effect on cardiac output of conversion from atrial fibrillation to normal sinus mechanism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9736134" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cardiac performance early after cardioversion from atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11545774" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8362771" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8195510" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9669270" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7671380" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9396475" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4859958" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hemodynamic effects of acute myocardial infarction in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3946254" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Importance of the "atrial kick" in determining the effective mitral valve orifice area in mitral stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1598871" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1396842" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10943231" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16863752" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8970422" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effect of an irregular ventricular rhythm on cardiac output.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12681998" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8970421" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10525512" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Left ventricular beat to beat performance in atrial fibrillation: dependence on contractility, preload, and afterload.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7594079" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9788831" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Myocardial contractility is not constant during spontaneous atrial fibrillation in patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9294986" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1382889" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Postextrasystolic potentiation and its contribution to the beat-to-beat variation of the pulse during atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1200036" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Left atrial transport function in myocardial infarction. Importance of its booster pump function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6831669" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6682616" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2329232" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18946063" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2950154" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9630109" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : N-terminal proANF in acute atrial fibrillation: a biochemical marker of atrial pressures but not a predictor for conversion to sinus rhythm. Digitalis in Acute Atrial Fibrillation (DAAF) Trial group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10758968" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12034150" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14583372" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Brain natriuretic peptide is elevated in outpatients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19552671" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation: an echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21939832" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8651134" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Effect of isolated left atrial enlargement on mitral annular size and valve competence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12020493" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12381084" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575053" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Catheter ablation for atrial fibrillation in congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9715865" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11156881" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12356634" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9857897" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : "Stunning" of the left atrium after spontaneous conversion of atrial fibrillation to sinus rhythm: demonstration by transesophageal Doppler techniques in a canine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227792" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9856921" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical and echocardiographic features influencing recovery of atrial function after cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9605054" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8996305" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8294679" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8752189" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3195481" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7754955" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8205657" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7817928" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12233921" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Safety of electrical cardioversion in patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9874066" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9133507" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8586473" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Evidence for the intravascular hyperclotting state induced by atrial fibrillation itself (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9164372" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Hemodynamic changes after cardioversion of chronic atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12595839" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12778026" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acute reductions in ventricular myocardial tissue velocities after direct current cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7686660" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Altered cardiac oxygen extraction, lactate production and coronary blood flow after large dose transthoracic DC countershocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8549199" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pulmonary edema following electrical cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2816702" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7917690" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7821314" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
